Potential protective associations of antidiabetic and lipid-lowering therapies with retinal vein occlusion risk: a systematic review and meta-analysis
Researchers evaluated the association between systemically administered antidiabetic or lipid-lowering agents and retinal vein occlusion (RVO). The study included six cohort studies and four case-control studies involving over 2 million adults. Meta-analysis results suggest that statin use consistently reduced RVO risk. Metformin monotherapy and GLP-1 receptor agonists showed signals of benefit, while findings for SGLT-2 inhibitors were inconsistent. These findings require confirmation in prospective studies.
What to check after reading
This review examines the association between antidiabetic and lipid-lowering therapies and RVO risk, finding evidence of reduced risk with statins but requiring further validation for other drugs.
Source
Calendar dates show when a case was added or scheduled. For event dates, check the original source.